过去一年中添加的文章，按日期排序
Diabetes, transplantation and regenerative medicine
A Mattina, D Baidal, B Marfil-Garza… - Frontiers in Clinical …, 2024 - frontiersin.org
120 天前 - … with insulin resistance and relative insulin deficiency, … kidney transplant in cases
of concomitant end-stage renal … and extraglycemic effects, including cardiovascular and renal …
of concomitant end-stage renal … and extraglycemic effects, including cardiovascular and renal …
[引用][C] Four biomarkers shown to predict the risk of progressive heart and kidney disease in people with type 2 diabetes with diabetic kidney disease
I Idris - 2023 - Wiley Online Library
298 天前 - … Investigators examined the effect of canagliflozin on … outcome (a composite of
end-stage kidney disease [dialysis, … a higher risk for these outcome compared with those with low …
end-stage kidney disease [dialysis, … a higher risk for these outcome compared with those with low …
Cardiorenal Risk Estimates in T2D Mediated by Common Biomarker Response to Canagliflozin.
G Halsey - Patient Care (Online), 2023 - go.gale.com
321 天前 - … development of cardiovascular and renal disease in an analysis … was a composite
of end-stage kidney disease (dialysis, … and colleagues analyzed the effect of canagliflozin on …
of end-stage kidney disease (dialysis, … and colleagues analyzed the effect of canagliflozin on …